Keros Therapeutics, Inc. (KROS) Nonoperating Income (Expense) USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Keros Therapeutics, Inc. quarterly Nonoperating Income (Expense) history and growth rate from 2019 to 2024.
  • Keros Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $5.37M, a 75.2% increase year-over-year.
  • Keros Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $19.3M, a 45.5% increase year-over-year.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $19.3M $5.37M +$2.3M +75.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $16.9M $6.21M +$3.97M +177% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q4 2023 $16.9M $16.9M +$6.84M +67.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $13M $3.84M -$627K -14% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $13.6M $3.83M +$370K +10.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $13.2M $3.07M +$3.13M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $10.1M $2.24M +$2.32M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q4 2022 $10.1M $10.1M +$10.5M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $7.79M $4.47M +$4.61M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $3.19M $3.46M +$3.54M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$354K -$60K +$6K +9.09% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$360K -$75K -$2.69M -103% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q4 2021 -$360K -$360K -$1.48M -132% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $2.33M -$138K -$50K -56.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $2.38M -$81K -$238K -152% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $2.62M -$66K +$1.49M +95.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1.12M $2.62M +$2.64M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-09
Q4 2020 $1.12M $1.12M +$2.9M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
Q3 2020 -$1.51M -$88K +$1.14M +92.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$2.65M $157K +$359K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$3.01M -$1.56M -$1.24M -380% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$1.77M -$23K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q4 2019 -$1.77M -$1.77M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 -$1.22M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$202K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$325K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.